Researchers report they have identified a protein that enables a toxic natural aggregate to spread from cell to cell in a mammal's brain -- and a way to block that protein's action. Their study in mice and cultured cells suggests that an immunotherapy already in clinical trials as a cancer therapy should also be tested as a way to slow the progress of Parkinson's disease, the researchers say.